NASDAQ·US·Drug Manufacturers - General
GILDGILD
0คะแนน
สรุป
ปานกลาง
ความมั่นใจ 89%
$128.84—
Today's session
Upside?
+24.9%
FV $160.88
P/E (TTM)?
19.0
Earnings yield
FCF yield?
4.7%
Mcap $159.92B
ถือ
Fundamental buy·Technical neutral
What investors notice
Key signs
Plain-language read of the metrics that matter most for this stock.
Strongly positive
7 · 0 · 1
Strengths
- Best-in-class return on equity22%
- High return on invested capital22%
- EPS compounding at double-digit pace23%
- Pristine fundamentals (Piotroski 7+)8/9
- Modestly undervalued vs. consensus FV25%
- ROIC well above cost of capital — value-creating17%
- Analyst consensus heavily Buy-skewed
Risks
- Inconsistent profitability4/10
Watchlist
None detected.
$128.84+26.9%
1Y · period change vs 2025-04-29
Score history (10y)
How quality has trended through cycles.
Verdict bands: 85+ Wonderful · 70 Solid · 55 Average · 40 Risky.
Fair value range
5 of 5 models · trimmed-mean consensus
Consensus FV
$160.88
Upside
+24.9%
Now $128.84
Our FV$160.88
Price$128.84
$40.13$262.80
Open the Fair Value tab to tweak WACC and growth, and to see all five model outputs side-by-side.
10-year financials
Annual revenue, profit, and free cash flow with year-over-year growth overlay.
YoY growth overlaid
Snapshot
At a glance
Top-line figures most investors check first.
Market cap
$159.92B
P/E (TTM)?
19.0
FCF yield?
4.7%
Dividend
$3.16
2.5% yield
52w range
$94.40 – $154.92
Score confidence
89%
Data completeness
Last updated 4/30/2026, 4:20:00 AM · Data via Yahoo Finance, FMP, EDGAR. Disclaimer